CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression

OncoImmunology

Volumn 4, Issue 5, 2015, Pages

  Bonnefoy, Nathalie ^a   Bastid, Jérémy ^b   Alberici, Gilles ^b   Bensussan, Armand ^c   Eliaou, Jean François ^a,d  

^a UNIV MONTPELLIER   (France)

^b OREGA Biotech   (France)

^c INSERM   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

A2A receptor; Adenosine; CD39; Immune checkpoints; PD1

Indexed keywords

5' NUCLEOTIDASE; CD39 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROGRAMMED DEATH 1 RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNITY; CANCER INFILTRATION; CANCER SURVIVAL; CELL PROLIFERATION; CYTOTOXICITY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; NERVE CELL DIFFERENTIATION; OVARY CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYROID CANCER; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR RESISTANCE;

EID: 84944463780     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2014.1003015     Document Type: Article

References (10)

1. Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 2014; 515:577-81; PMID:25428507; http://dx.doi.org/ 10.1038/nature13988.
2. Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, Huang X, Caldwell S, Liu K, Smith P, et al. A2A adenosine receptor protects tumors from antitumor T cells. Pro Natl Acad Sci USA 2006; 103:13132-7; http://dx.doi.org/10.1073/pnas.0605251103.
3. Stagg J, Beavis PA, Divisekera U, Liu MC, Moller A, Darcy PK, Smyth MJ. CD73-deficient mice are resistant to carcinogenesis. Cancer Res 2012; 72:2190-6; PMID:22396496; http://dx.doi.org/10.1158/0008-5472.CAN-12-0420.
4. Jackson SW, Hoshi T, Wu Y, Sun X, Enjyoji K, Cszimadia E, Sundberg C, Robson SC. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/ Entpd1-null mice. Am J Pathol 2007; 171:1395-404; PMID:17823293; http://dx.doi.org/10.2353/ajpath. 2007.070190.
5. Chalmin F, Mignot G, Bruchard M, Chevriaux A, Vegran F, Hichami A, Ladoire S, Derangère V, Vincent J, Masson D, et al. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity 2012; 36:362-73; PMID:22406269; http://dx.doi.org/ 10.1016/j.immuni.2011.12.019.
6. Hausler SF, Montalban del Barrio I, Strohschein J, Anoop Chandran P, Engel JB, Honig A, Ossadnik M, Horn E, Fischer B, Krockenberger M, et al. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. Cancer Immunol Immunother 2011; 60:1405-18; PMID:21638125; http://dx.doi.org/10.1007/s00262-011-1040-4.
7. Bastid J, Regairaz A, Bonnefoy N, Dejou C, Guistiniani J, Laheurte C, Cochaud S, Laprevotte E, Funck-Brentano E, Hemon P, et al. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity. Cancer Immunol Res 2014; 3(3):254-65 Nov 17. pii: canimm.0018.2014; PMID:25403716; http://dx.doi. org/10.1158/2326-6066.CIR-14-0018
8. Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K, et al. Anticancer chemotherapyinduced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity 2013; 38:729-41; PMID:23562161; http://dx.doi.org/10.1016/j. immuni.2013.03.003.
9. Ko A, Kanehisa A, Martins I, Senovilla L, Chargari C, Dugue D, Mariño G, Kepp O, Michaud M, Perfettini JL, et al. Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ 2014; 21:92-9; PMID:24037090; http://dx.doi.org/ 10.1038/cdd.2013.124.
10. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334:1573-7; PMID:22174255; http://dx.doi.org/10.1126/science.1208347.